HealthOrbit, Inc. - News Headlines

	Biogen Idec and Abbott Announce Enrollment of First Patient in Global Phase III Study of Daclizumab for Relapsing-Remitting Multiple Sclerosis (05.25.10)
	Abbott Statement: ACCORD Lipid Results Support Treatment Guidelines for Fibrate Use (03.16.10)
	Pfizer And Protalix Enter Into Agreement To Develop And Commercialize Gaucher’s Disease Treatment (12.02.09)
	Sanofi-aventis Completes Acquisition of Merck's Interest in Merial (09.19.09)
	The Makers Of LISTERINE® And REACH® TOTAL CARE Products Unveil A New Laugh-Out-Loud Book Benefiting The National Children’s Oral Health Foundation®: America's Toothfairy (09.18.09)
	Merck & Co., Inc. Named to Dow Jones Sustainability North America Index (09.9.09)
	Icagen Announces Lifting of Partial Clinical Hold of ICA-105665 (08.7.09)
	Lexicon Initiates Phase 2 Clinical Trial of LX2931 in Patients with Rheumatoid Arthritis (08.7.09)
	Abbott and AstraZeneca Submit New Drug Application to the FDA for CERTRIAD™, an Investigational Treatment for Mixed Dyslipidemia (06.05.09)
	Abbott and AstraZeneca Extend Relationship to Include Co-promotion of TRILIPIX® (fenofibric acid) (06.05.09)